All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)- 15:05, 26 November 2023 Jwarner talk contribs moved page Allogeneic HSCT to Allogeneic HSCT conditioning regimens over redirect
- 15:05, 26 November 2023 Jwarner talk contribs deleted redirect Allogeneic HSCT conditioning regimens by overwriting (Deleted to make way for move from "Allogeneic HSCT")
- 13:55, 26 November 2023 Jwarner talk contribs moved page Niraparib and Abiraterone (Akeega) to Niraparib and abiraterone (Akeega)
- 03:09, 26 November 2023 Jwarner talk contribs moved page Mycostatin (Nystatin) to Nystatin (Mycostatin) (error in brand naming)
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP2 inhibitors (Created page with "Category:PARP inhibitors")
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP1 inhibitors (Created page with "Category:PARP inhibitors")
- 18:05, 19 November 2023 Jwarner talk contribs created page Category:TYK2 inhibitors (Created page with "A member of the Janus kinase family of tyrosine kinases. Category:JAK inhibitors")
- 14:14, 18 November 2023 Jwarner talk contribs moved page Toripalimab (Loqtorz) to Toripalimab (Loqtorzi) (Brand name not spelled right)
- 15:10, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, third generation (Created page with "Category:Aromatase inhibitors")
- 15:09, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, second generation (Created page with "Category:Aromatase inhibitors")
- 15:08, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, first generation (Created page with "Category:Aromatase inhibitors")
- 15:03, 17 November 2023 Jwarner talk contribs created page Category:PMDA approved in 1995 (Created page with "Category:PMDA approved drugs")
- 14:26, 17 November 2023 Jwarner talk contribs moved page Anlotinib (AL-3818) to Anlotinib (Fukewei) (brand name)
- 12:32, 17 November 2023 Jwarner talk contribs moved page Capivasertib (AZD-5363) to Capivasertib (Truqap) (FDA approval)
- 11:50, 17 November 2023 Jwarner talk contribs created page Thyroid cancer, medullary - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:16, 15 November 2023 Jwarner talk contribs created page NCCN guidelines (Created page with "This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:44, 13 November 2023 Jwarner talk contribs created page Upper tract urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:12, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1977 (Created page with "Category:EMA approved drugs")
- 17:12, 7 November 2023 Jwarner talk contribs moved page Bacillus Calmette-Guérin (BCG) to BCG vaccine (INN)
- 01:28, 7 November 2023 Jwarner talk contribs created page CRC (Redirected page to Colorectal cancer) Tag: New redirect
- 01:00, 7 November 2023 Jwarner talk contribs created page Category:Warm autoimmune hemolytic anemia medications (Created page with "Category:Classical hematology medications")
- 00:59, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1955 (Created page with "Category:EMA approved drugs")
- 00:55, 7 November 2023 Jwarner talk contribs created page Category:Colorectal cancer medications (historic) (Created page with "Category:Colorectal cancer medications")
- 23:16, 6 November 2023 Jwarner talk contribs created page Category:Acquired hemophilia A medications (Created page with "Category:Acquired coagulopathy medications")
- 20:57, 6 November 2023 Jwarner talk contribs created page Mitomycin pyelocalyceal (Jelmyto) (Created page with "==Mechanism of action== Antibiotic oncologic isolated from Streptomyces caespitosus; inhibits DNA synthesis and induces crosslinking. Formulated for pyelocalyceal infusion. =...")
- 20:28, 6 November 2023 Jwarner talk contribs created page Lasofoxifene (Fablyn) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lasofoxifene NCI Drug Dictionary]: A non-steroidal, naphthalene-derived, thi...")
- 20:08, 6 November 2023 Jwarner talk contribs created page Fadrozole (Afema) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride NCI Data Dictionary]: The hydrochloride salt of the...")
- 19:33, 6 November 2023 Jwarner talk contribs created page Dinutuximab beta (Qarziba) (Created page with "==Mechanism of action== Anti-GD2 antibody ==Diseases for which it is used== *Neuroblastoma ==History of changes in EMA indication== *2017-05-08: Initial authorisation as...")
- 19:04, 6 November 2023 Jwarner talk contribs created page Chlorozotocin (DCNU) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin NCI Drug Dictionary]: A glucose-linked chloroethylnitrosourea...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-zerc (Zercepac) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Zercepac Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-herw (Herwenda) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Herwenda Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixi (Riximyo) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Riximyo Category:Drugs Category:Intravenous medications Category:Neutral Cate...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixa (Rixathon) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Rixathon Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rite (Ritemvia) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Ritemvia Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-blit (Blitzima) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Blitzima Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:57, 6 November 2023 Jwarner talk contribs created page Bevacizumab-onbe (Onbevzi) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Onbevzi Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-equi (Equidacent) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Equidacent Category:Drugs Category:Intravenous medications Category:Neutral [...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-aybi (Aybintio) (Created page with "'''Note: this is a bevacizumab biosimilar.'' ==Also known as== *'''Brand name:''' Aybintio Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 13:59, 6 November 2023 Jwarner talk contribs created page Anlotinib (AL-3818) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catequentinib-hydrochloride NCI Drug Dictionary]: The hydrochloride salt for...")
- 12:15, 6 November 2023 Jwarner talk contribs created page Cutaneous squamous cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:04, 5 November 2023 Jwarner talk contribs created page Systemic mastocytosis - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:54, 5 November 2023 Jwarner talk contribs created page Polycythemia vera - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:12, 5 November 2023 Jwarner talk contribs created page Meningioma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:07, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:00, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:36, 5 November 2023 Jwarner talk contribs created page JMML (Redirected page to Juvenile myelomonocytic leukemia) Tag: New redirect
- 00:14, 4 November 2023 Jwarner talk contribs moved page Fruquintinib (HMPL-013) to Fruquintinib (Elunate) (brand name)
- 20:52, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:49, 3 November 2023 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant regimens (Created page with "Category:Acute lymphoblastic leukemia regimens")
- 20:48, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:37, 1 November 2023 Jwarner talk contribs created page Merkel cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 10:59, 31 October 2023 Jwarner talk contribs created page Motixafortide (Aphexda) (Created page with "cyclic-peptide CXCR4 inhibitor Category:Drugs Category:CXCR4 inhibitor Category:FDA approved in 2023 Category:Stub")
- 23:34, 28 October 2023 Jwarner talk contribs created page Category:Anti-CLDN18.2 antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 23:33, 28 October 2023 Jwarner talk contribs created page Category:Gastric cancer medications (investigational) (Created page with "Category:Gastric cancer medications")
- 23:33, 28 October 2023 Jwarner talk contribs created page Zolbetuximab (IMAB-362) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab NCI Drug Dictionary]: A chimeric immunoglobulin G1 (IgG1) monoc...")
- 21:53, 28 October 2023 Jwarner talk contribs created page Fitusiran (ALN-AT3SC) (Created page with "==Mechanism of action== siRNA therapeutic, targets antithrombin ==Preliminary data== ===Inherited coagulopathy=== #'''ATLAS-A/B:''' Srivastava A, Rangarajan S, Kavakli K,...")
- 21:34, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 21:31, 28 October 2023 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease regimens (Created page with "Regimens with some demonstrated degree of efficacy in the treatment of hepatic veno-occlusive disease.")
- 21:30, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:45, 26 October 2023 Jwarner talk contribs created page ASCO guidelines (Created page with "This page will be a gathering place for the American Society of Clinical Oncology (ASCO) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:51, 25 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome, IDH-mutated (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:32, 24 October 2023 Jwarner talk contribs created page Category:KFDA approved in 2021 (Created page with "Category:KFDA approved drugs")
- 23:31, 24 October 2023 Jwarner talk contribs created page Lazertinib (Leclaza) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib NCI Drug Dictionary]: An orally available third-g...")
- 22:44, 15 October 2023 Jwarner talk contribs created page ESMO guidelines (Created page with "This page will be a gathering place for ESMO guidelines that do not clearly fit under a disease-specific page. =Fertility & Pregnancy= *'''2013:''' Peccatori et al. [https://...")
- 20:38, 14 October 2023 Jwarner talk contribs created page Tenosynovial giant cell tumor - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:34, 14 October 2023 Jwarner talk contribs created page Subependymal giant cell astrocytoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:08, 14 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:42, 11 October 2023 Jwarner talk contribs created page PJP Prophylaxis (Created page with "The purpose of this page is to list the various types of PJP prophylaxis in common usage. ==Guidelines== ==Prophylaxis== ===Trimethoprim-Sulfamethoxazole (Bactrim DS)|Tri...")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-Factor IXa/Factor Xa bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-EGFR/HGFR bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:50, 3 October 2023 Jwarner talk contribs moved page Category:Anti-GPRC5D bispecific T-cell engager antibodies to Category:Anti-GPRC5D/CD3 bispecific antibodies
- 20:47, 3 October 2023 Jwarner talk contribs moved page Category:Anti-EpCAM bispecific T-cell engager antibodies to Category:Anti-EpCAM/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD33 bispecific T-cell engager antibodies to Category:Anti-CD33/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD19 bispecific T-cell engager antibodies to Category:Anti-CD19/CD3 bispecific antibodies
- 20:43, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD20 bispecific T-cell engager antibodies to Category:Anti-CD20/CD3 bispecific antibodies
- 20:40, 3 October 2023 Jwarner talk contribs moved page Category:Anti-BCMA bispecific T-cell engager antibodies to Category:Anti-BCMA/CD3 bispecific antibodies
- 19:56, 3 October 2023 Jwarner talk contribs created page Category:Small bowel adenocarcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 22:20, 1 October 2023 Jwarner talk contribs created page Category:PMDA approved in 1981 (Created page with "Category:PMDA approved drugs")
- 22:15, 1 October 2023 Jwarner talk contribs created page Category:Loop diuretics (Created page with "Category:Diuretics")
- 21:45, 1 October 2023 Jwarner talk contribs created page Category:Light-chain (AL) amyloidosis medications (investigational) (Created page with "Category:Light-chain (AL) amyloidosis medications")
- 15:22, 29 September 2023 Jwarner talk contribs moved page Folinic acid (Leucovorin) to Leucovorin (Folinic acid) (Alignment with INN)
- 20:13, 26 September 2023 Jwarner talk contribs created page Germ cell tumor (Created page with "At this point we do not have a dedicated page for germ cell tumors. More information about this broad class of tumors can be found [https://en.wikipedia.org/wiki/Germ_cell_tum...")
- 15:22, 23 September 2023 Jwarner talk contribs created page Category:Malignant neoplasm (Created page with "Category:Condition")
- 14:30, 23 September 2023 Jwarner talk contribs created page Category:TGF-beta inhibitors (Created page with "Category:Erythrocyte growth factors")
- 14:24, 23 September 2023 Jwarner talk contribs created page Category:Urate oxidase (Created page with "Category:Uric acid lowering agents")
- 12:16, 23 September 2023 Jwarner talk contribs created page Category:Synthetic muramyl dipeptides (Created page with "Category:Immunotherapeutic")
- 11:51, 23 September 2023 Jwarner talk contribs created page Category:GnRH analogs (Created page with "Category:Endocrine therapeutic")
- 11:27, 23 September 2023 Jwarner talk contribs created page Category:JAK3 inhibitors (Created page with "Category:JAK inhibitors")
- 11:25, 23 September 2023 Jwarner talk contribs created page Category:JAK1 inhibitors (Created page with "Category:JAK inhibitors")
- 11:24, 23 September 2023 Jwarner talk contribs created page Category:JAK2 inhibitors (Created page with "Category:JAK inhibitors")
- 00:29, 23 September 2023 Jwarner talk contribs created page Category:Anti-IL-2R immunotoxins (Created page with "Category:Immunotoxin")
- 00:12, 23 September 2023 Jwarner talk contribs created page Category:Topoisomerase II inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 23:38, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) medications to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications
- 23:37, 22 September 2023 Jwarner talk contribs moved page SMO or PTCH-1 (Hedgehog) to Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog)
- 23:37, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) regimens to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) regimens
- 23:33, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H medications to Category:Malignant solid neoplasm, TMB-H medications
- 23:32, 22 September 2023 Jwarner talk contribs moved page TMB-H to Malignant solid neoplasm, TMB-H
- 23:32, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H regimens to Category:Malignant solid neoplasm, TMB-H regimens
- 23:31, 22 September 2023 Jwarner talk contribs moved page Category:RET medications to Category:Malignant solid neoplasm, RET-mutated medications
- 23:30, 22 September 2023 Jwarner talk contribs moved page RET to Malignant solid neoplasm, RET-mutated